These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17594730)

  • 1. Mucolytics, expectorants, and mucokinetic medications.
    Rubin BK
    Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the efficacy of mucoactive aerosol therapy.
    Fuloria M; Rubin BK
    Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus structure and properties in cystic fibrosis.
    Rubin BK
    Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other medications for aerosol delivery.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S76-9. PubMed ID: 16798603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosol Medications for Treatment of Mucus Clearance Disorders.
    Rubin BK
    Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiology of airway mucus clearance.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.
    Broughton-Head VJ; Smith JR; Shur J; Shute JK
    Pulm Pharmacol Ther; 2007; 20(6):708-17. PubMed ID: 17055310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucus and mucins.
    Rubin BK
    Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other mucoactive agents for cystic fibrosis.
    Bye PT; Elkins MR
    Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus-controlling agents: past and present.
    King M; Rubin BK
    Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies.
    Hurt K; Bilton D
    Respiration; 2014; 88(6):441-8. PubMed ID: 25472021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
    Miyata T
    Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoactive drugs.
    Balsamo R; Lanata L; Egan CG
    Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4.
    Kater A; Henke MO; Rubin BK
    Ann N Y Acad Sci; 2007 Sep; 1112():140-53. PubMed ID: 17496063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.